FDA Panel Backs Approval Of Drug For HIV Prevention
A U.S. Food and Drug Administration advisory committee on Thursday recommended that the FDA approve Gilead Sciences Inc.'s Truvada, an antiviral drug that could prevent HIV, with some lauding it as...To view the full article, register now.
Already a subscriber? Click here to view full article